Literature DB >> 12109441

Macrophage migration inhibitory factor activates antigen-presenting dendritic cells and induces inflammatory cytokines in ulcerative colitis.

H Murakami1, S M F Akbar, H Matsui, N Horiike, M Onji.   

Abstract

The level of macrophage migration inhibitory factor (MIF) and the functions of dendritic cells (DC) are up-regulated in the peripheral blood, and the numbers of MIF-expressing cells and mature DC are increased at the colonic mucosa from patients with ulcerative colitis (UC). However, a functional relationship between MIF and DC, and the role of MIF in the pathogenesis of UC, are not clear. In this study, we showed that a pure population of peripheral blood DC is a new and still unknown source of MIF. DC from UC patients produced significantly higher levels of MIF (17 x 5 +/- 9 x 8 ng/ml, n = 10) compared with patients with Crohns disease (CD) (4 x 6 +/- 2 x 5 ng/ml, n = 5, P< 0 x 01) and control subjects (5 x 0 +/- 2 x 6 ng/ml, n = 10, P< 0 x 01). A double immunofluorescence study revealed the expression of MIF by CD83-positive mature DC at the colonic mucosa from UC patients. Blood DC treated with high amounts of MIF (500 ng/ml) showed a significantly higher stimulatory capacity (43287 +/- 5998 CPM, n = 5) in an allogenic mixed leucocyte reaction compared with untreated DC (27528 +/- 8823 CPM, n = 5, P< 0 x 05). Study of intracellular cytokine expression showed that MIF induced significant levels of interleukin (IL)-1 and IL-8 in monocytes and DC from UC and CD patients. These results showing the capacity of MIF to induce increased functional capacity of DC, and to produce IL-1 and IL-8 from monocytes and DC, indicate a role of MIF in the induction and/or perpetuation of the inflammatory environment in UC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12109441      PMCID: PMC1906246          DOI: 10.1046/j.1365-2249.2002.01838.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Flow cytometric analysis of cytokine production by normal human peripheral blood dendritic cells and monocytes: comparative analysis of different stimuli, secretion-blocking agents and incubation periods.

Authors:  C Bueno; J Almeida; M C Alguero; M L Sánchez; J M Vaquero; F J Laso; J F San Miguel; L Escribano; A Orfao
Journal:  Cytometry       Date:  2001-02-15

2.  Characterization of antigen-presenting dendritic cells in the peripheral blood and colonic mucosa of patients with ulcerative colitis.

Authors:  Y Ikeda; F Akbar; H Matsui; M Onji
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-07       Impact factor: 2.566

3.  Local and systemic liberation of proinflammatory cytokines in ulcerative colitis.

Authors:  M Gotteland; M Lopez; C Muñoz; R Saez; H Altshiller; P Llorens; O Brunser
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

4.  Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance.

Authors:  H Murakami; S M Akbar; H Matsui; M Onji
Journal:  Eur J Clin Invest       Date:  2001-04       Impact factor: 4.686

5.  Migration and maturation of human colonic dendritic cells.

Authors:  S J Bell; R Rigby; N English; S D Mann; S C Knight; M A Kamm; A J Stagg
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

6.  Regulation of the CTL response by macrophage migration inhibitory factor.

Authors:  R Abe; T Peng; J Sailors; R Bucala; C N Metz
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

Review 7.  Manipulation of cytokines in the management of patients with inflammatory bowel disease.

Authors:  G Monteleone; T T MacDonald
Journal:  Ann Med       Date:  2000-11       Impact factor: 4.709

Review 8.  Inflammatory bowel disease: immunologic concepts.

Authors:  S Schreiber
Journal:  Hepatogastroenterology       Date:  2000 Jan-Feb

Review 9.  Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth.

Authors:  J Nishihira
Journal:  J Interferon Cytokine Res       Date:  2000-09       Impact factor: 2.607

Review 10.  Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question.

Authors:  M F Neurath; S Finotto; I Fuss; M Boirivant; P R Galle; W Strober
Journal:  Trends Immunol       Date:  2001-01       Impact factor: 16.687

View more
  18 in total

1.  Macrophage migration inhibitory factor gene -173G>C polymorphism and risk of bladder cancer in southeast China: a case-control analysis.

Authors:  Qinbo Yuan; Meilin Wang; Miaomiao Wang; Zhengdong Zhang; Wei Zhang
Journal:  Mol Biol Rep       Date:  2011-07-13       Impact factor: 2.316

Review 2.  Securing the immune tightrope: mononuclear phagocytes in the intestinal lamina propria.

Authors:  Chen Varol; Ehud Zigmond; Steffen Jung
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

Review 3.  Role of mucosal dendritic cells in inflammatory bowel disease.

Authors:  Jan Hendrik Niess
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

Review 4.  Dendritic cells in intestinal homeostasis and disease.

Authors:  Maria Rescigno; Antonio Di Sabatino
Journal:  J Clin Invest       Date:  2009-09-01       Impact factor: 14.808

5.  Pathophysiological significance of a reaction in mouse gastrointestinal tract associated with delayed-type hypersensitivity.

Authors:  Wan-Gui Yu; Ping Lin; Hui Pan; Lan Xiao; En-Cong Gong; Lin Mei
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

6.  Decreased interferon-alpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C.

Authors:  H Murakami; S M F Akbar; H Matsui; N Horiike; M Onji
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

7.  Isolation and functional analysis of circulating dendritic cells from hepatitis C virus (HCV) RNA-positive and HCV RNA-negative patients with chronic hepatitis C: role of antiviral therapy.

Authors:  E Tsubouchi; S M F Akbar; H Murakami; N Horiike; M Onji
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

Review 8.  The role of macrophage migration inhibitory factor on glucose metabolism and diabetes.

Authors:  C Toso; J A Emamaullee; S Merani; A M J Shapiro
Journal:  Diabetologia       Date:  2008-07-09       Impact factor: 10.122

9.  Meta-analysis of macrophage migration inhibitory factor (MIF) gene -173G/C polymorphism and inflammatory bowel disease (IBD) risk.

Authors:  Jianfeng Yang; Yanqi Li; Xiaofeng Zhang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

10.  Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondii.

Authors:  Marcos Flores; Rafael Saavedra; Rocio Bautista; Rubi Viedma; Eda P Tenorio; Lin Leng; Yuriko Sánchez; Imelda Juárez; Anjali A Satoskar; Asha S Shenoy; Luis I Terrazas; Richard Bucala; Joseph Barbi; Abhay R Satoskar; Miriam Rodriguez-Sosa
Journal:  FASEB J       Date:  2008-07-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.